Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2021 Publisher: Norgine Pharmaceuticals Limited, Norgine House, Widewater Place, Moorhall Road, Harefield, Uxbridge, UB9 6NS, UK
TARGAXAN 550 mg film-coated tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablet. Pink, oval biconvex 10 mm x 19 mm film-coated tablets embossed with “RX” on one side. |
Each film-coated tablet contains 550 mg rifaximin.
Excipients: For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Rifaximin |
Rifaximin is an antibacterial agent of the rifamycin class that inhibits bacterial RNA synthesis. Rifaximin has a broad antimicrobial spectrum against most of the Gram-positive and -negative, aerobic and anaerobic bacteria responsible for intestinal infections. |
| List of Excipients |
|---|
|
Tablet core: Sodium starch glycolate type A Film coat (opadry oy-s-34907): Hypromellose |
PVC-PE-PVDC/Aluminium foil blisters in cartons of 14, 28, 42, 56 or 98 tablets.
Not all pack-sizes may be marketed.
Norgine Pharmaceuticals Limited, Norgine House, Widewater Place, Moorhall Road, Harefield, Uxbridge, UB9 6NS, UK
PL 20011/0020
10/01/2013
| Drug | Countries | |
|---|---|---|
| TARGAXAN | Finland, Ireland, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
